More than 50% of patients who survived stroke have a chronic disability. The National Institute Health Stroke Scale (NIHSS) is scoring system to determine the neurologic deficit patient. This study analyzed severity based on baseline NIHSS score as determinant for 30-day post-ischemic method uses retrospective cohort design medical records and registry ischemic in Bethesda Hospital Yogyakarta. ...

Background: Factor VIII administration to hemophilia A patients results in an immune response (inhibitor formation) which significantly complicates the therapy. The present study was performed to determine the prevalence of inhibitor development in hemophilia A patients receiving recombinant factor VIII therapy. Materials and Methods: This was an observational descriptive study. Clotting fac...

OBJECTIVE To assess the impact of the recommendation of the 2001 Bethesda System to report all benign-appearing endometrial cells seen in women aged > or = 40 years on the frequency with which endometrial carcinomas are potentially detected as a consequence of Pap test reports that mention endometrial cells. STUDY DESIGN We identified all women diagnosed with endometrial adenocarcinoma who al...

BACKGROUND Cytologically indeterminate thyroid nodules represent a diagnostic and therapeutic challenge. In 2007, the National Cancer Institute recommended The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) as a means of improving the accuracy of thyroid cytopathology. Our objective was to determine the effect of TBSRTC on thyroidectomy rates and malignancy risk in cytologically i...

OBJECTIVE To evaluate the accuracy and utility of intraoperative frozen section examination (iFSE) in patients with a preoperative fine-needle aspiration (FNA) cytology of "suspicious for malignancy" (SFM)-Bethesda V, after the adoption of the Bethesda System for Reporting Thyroid Cytopathology. STUDY DESIGN Case series with chart review. SETTING Tertiary medical center. SUBJECTS AND METH...

B. Turkbey, H. Mani, M. Bernardo, Y. Pang, K. Khurana, P. Albert, P. Pinto, M. Merino, and P. L. Choyke Molecular Imaging Program, NCI, NIH, Bethesda, MD, United States, Laboratory of Pathology, NCI, NIH, Bethesda, MD, United States, Philips Healthcare, Bethesda, MD, United States, Urologic Oncology Branch, NCI, NIH, Bethesda, MD, United States, Biometric Research Branch, Division of Cancer Tre...

BACKGROUND AND PURPOSE Bethesda class III cytology is an important limitation of the US-FNA in assessing thyroid nodules. This study aimed to assess the diagnostic efficacy of US in evaluating thyroid nodules with Bethesda class III cytology. MATERIALS AND METHODS From January 2008 to December 2009, 1036 patients with 1289 thyroid nodules diagnosed by US and subsequent US-FNA biopsy were enro...